Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (activ in Chf) Investigators. Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure: a Randomized Controlled Trial